Age disparity in the dissemination of imatinib for treating chronic myeloid leukemia

Medicine and Dentistry

• Imatinib 100%
• Chronic Myelogenous Leukemia 66%
• Age 50%
• Patient 50%
• Elderly Patient 33%
• Combination Therapy 25%
• Leukemia Survival 25%
• Disparity 16%
• Survival Rate 16%
• Mortality Rate 16%
• Surveillance, Epidemiology, and End Results 16%
• Survival 16%
• Therapeutic Procedure 16%
• Population 8%
• Cancer Registry 8%
• Mortality 8%
• Race 8%

Nursing and Health Professions

• Imatinib 100%
• Chronic Myeloid Leukemia 66%
• Combination Therapy 25%
• Survival Rate 16%
• Mortality Rate 16%
• Socioeconomic Status 16%
• Survival 16%
• Physician 8%
• Medical Record 8%
• Food and Drug Administration 8%
• National Health Organization 8%
• Population 8%
• Time 8%
• Procedures 8%
• Mortality 8%
• Cancer Registry 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Imatinib 100%
• Chronic Myeloid Leukemia 66%
• Survival Rate 16%
• Mortality Rate 16%
• Survival 16%
• Mortality 8%